UNITED STATES APHERESIS MARKET FORECAST 2021-2026

The United States apheresis market is predicted to develop with a CAGR of 8.27% during the estimated period. Key drivers such as the increasing numbers of clinical trials associated with apheresis, the growing focus on treating different diseases through the apheresis technique, the surging need for blood components, and the rising concerns about blood safety are anticipated to fuel the market growth in the country. The base year considered for the market study is 2020 and the forecast years are from 2021 to 2026.

united-states-apheresis-market

The American Society for Apheresis (ASFA) aims to advance apheresis medicine for donors, patients, and practitioners through evidence-based practice, education, advocacy, and research. Hence, the increasing awareness about apheresis treatment significantly contributes to the growth of the market in the United States.

On the other hand, the surging cases of COVID-19 in the United States have substantially influenced the market studied. Marker Therapeutics AGhas and Terumo Blood and Cell Technologies (BCT) Inc announced that an Emergency Use Authorization (EUA) was issued by the Food and Drug Administration (FDA) for using the Spectra Optia Apheresis System by BCT and Marker Therapeutics’ D2000 Adsorption Cartridge, in April 2020. The measure would be beneficial for treating confirmed cases of COVID-19 in patients aged 18 and over. As a result, these factors are anticipated to facilitate the market in the United States over the forecasted period.

Baxter International Inc, headquartered in the United States, is a healthcare firm offering a diverse range of products across the portfolio of sterile intravenous (IV) solutions, acute and chronic dialysis therapies, inhaled anesthetics, generic injectable pharmaceuticals, infusion systems and devices, and parenteral nutrition therapies, among others. It caters to nursing homes, hospitals, doctors’ offices, rehabilitation centers, kidney dialysis centers, and patients under the supervision of general physicians.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS
    4. KEY GROWTH ENABLERS
    5. KEY CHALLENGES
  3. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON APHERESIS MARKET
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRY
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  4. MARKET BY PROCEDURE
    1. PLASMAPHERESIS
    2. PLATELETPHERESIS
    3. LEUKAPHERESIS
    4. ERYTHROCYTAPHERESIS
    5. OTHER APHERESIS PROCEDURES
  5. MARKET BY TECHNOLOGY
    1. CENTRIFUGATION
    2. MEMBRANE SEPARATION
  6. MARKET BY PRODUCT
    1. DISPOSABLE APHERESIS KITS
    2. APHERESIS MACHINE
  7. MARKET BY APPLICATION
    1. HEMATOLOGICAL DISORDERS
    2. NEUROLOGICAL DISORDERS
    3. AUTOIMMUNE DISORDERS
    4. RENAL DISORDERS
    5. OTHER APPLICATIONS
  8. MARKET BY END-USER
    1. BLOOD BANKS/ BLOOD DONATION CENTERS
    2. HOSPITALS & CLINICS
    3. AMBULATORY SURGICAL CENTERS
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
      4. BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
    2. COMPANY PROFILES
      1. ASAHI KASEI CORPORATION
      2. B BRAUN MELSUNGEN AG
      3. BAXTER INTERNATIONAL INC
      4. CYTOSORBENTS CORPORATION
      5. HEMACARE CORPORATION
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - APHERESIS

TABLE 2: UNITED STATES APHERESIS MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: UNITED STATES APHERESIS MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 4: UNITED STATES APHERESIS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: UNITED STATES APHERESIS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 6: UNITED STATES APHERESIS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: UNITED STATES APHERESIS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 8: UNITED STATES APHERESIS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: UNITED STATES APHERESIS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 10: UNITED STATES APHERESIS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: UNITED STATES APHERESIS MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 12: LIST OF MERGERS & ACQUISITIONS

TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 14: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS

TABLE 15: LIST OF BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS

LIST OF FIGURES

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: KEY MARKET TRENDS

FIGURE 5: UNITED STATES APHERESIS MARKET, BY PROCEDURE, IN 2020

FIGURE 6: UNITED STATES APHERESIS MARKET, BY PLASMAPHERESIS, 2021-2026 (IN $ MILLION)

FIGURE 7: UNITED STATES APHERESIS MARKET, BY PLATELETPHERESIS, 2021-2026 (IN $ MILLION)

FIGURE 8: UNITED STATES APHERESIS MARKET, BY LEUKAPHERESIS, 2021-2026 (IN $ MILLION)

FIGURE 9: UNITED STATES APHERESIS MARKET, BY ERYTHROCYTAPHERESIS, 2021-2026 (IN $ MILLION)

FIGURE 10: UNITED STATES APHERESIS MARKET, BY OTHER APHERESIS PROCEDURES, 2021-2026 (IN $ MILLION)

FIGURE 11: UNITED STATES APHERESIS MARKET, BY TECHNOLOGY, IN 2020

FIGURE 12: UNITED STATES APHERESIS MARKET, BY CENTRIFUGATION, 2021-2026 (IN $ MILLION)

FIGURE 13: UNITED STATES APHERESIS MARKET, BY MEMBRANE SEPARATION, 2021-2026 (IN $ MILLION)

FIGURE 14: UNITED STATES APHERESIS MARKET, BY PRODUCT, IN 2020

FIGURE 15: UNITED STATES APHERESIS MARKET, BY DISPOSABLE APHERESIS KITS, 2021-2026 (IN $ MILLION)

FIGURE 16: UNITED STATES APHERESIS MARKET, BY APHERESIS MACHINE, 2021-2026 (IN $ MILLION)

FIGURE 17: UNITED STATES APHERESIS MARKET, BY APPLICATION, IN 2020

FIGURE 18: UNITED STATES APHERESIS MARKET, BY HEMATOLOGICAL DISORDERS, 2021-2026 (IN $ MILLION)

FIGURE 19: PREVALENCE OF BLEEDING DISORDER IN UNITED STATES, 2019

FIGURE 20: UNITED STATES APHERESIS MARKET, BY NEUROLOGICAL DISORDERS, 2021-2026 (IN $ MILLION)

FIGURE 21: UNITED STATES APHERESIS MARKET, BY AUTOIMMUNE DISORDERS, 2021-2026 (IN $ MILLION)

FIGURE 22: UNITED STATES APHERESIS MARKET, BY RENAL DISORDERS, 2021-2026 (IN $ MILLION)

FIGURE 23: UNITED STATES APHERESIS MARKET, BY OTHER APPLICATIONS, 2021-2026 (IN $ MILLION)

FIGURE 24: UNITED STATES APHERESIS MARKET, BY END-USER, IN 2020

FIGURE 25: UNITED STATES APHERESIS MARKET, BY BLOOD BANKS/ BLOOD DONATION CENTERS, 2021-2026 (IN $ MILLION)

FIGURE 26: UNITED STATES APHERESIS MARKET, BY HOSPITALS & CLINICS, 2021-2026 (IN $ MILLION)

FIGURE 27: UNITED STATES APHERESIS MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2026 (IN $ MILLION)

Request For A Free Sample